Lab Reports

MRN: MRN-2024-001 • 11/20/2024

Patient shows significant decline in kidney function with eGFR dropping from 22 to 18 mL/min/1.73m². Combined with elevated potassium (6.2 mEq/L) and rising creatinine (3.8 mg/dL), this indicates progression to Stage 5 CKD. Immediate physician notification recommended for potential dialysis evaluation and urgent potassium management.

MRN: MRN-2024-003 • 11/20/2024

Moderate CKD progression with declining eGFR (24 mL/min) and elevated potassium (5.3 mEq/L). Close monitoring recommended to prevent further deterioration.

MRN: MRN-2024-002 • 11/19/2024 • Notified: Dr. Michael Chen

Gradual progression of CKD Stage 4. eGFR decline of ~10% warrants close monitoring but no immediate intervention required. Patient maintaining stable electrolyte balance.

MRN: MRN-2024-004 • 11/18/2024 • Notified: Dr. Priya Patel

Critical hyperkalemia requiring immediate intervention. Patient was contacted and medication adjustments made. Potassium normalized with loop diuretic increase and dietary modifications.

MRN: MRN-2024-005 • 11/17/2024 • Notified: Dr. Sarah Johnson

Critical hyperkalemia and severe kidney function decline (eGFR 9). Patient admitted for urgent hemodialysis initiation. Temporary catheter placed, first dialysis session completed successfully.

MRN: MRN-2024-006 • 11/15/2024 • Notified: Dr. Michael Chen

All values within normal limits. Anemia management effective with current ESA dosing. Calcium-phosphate balance well controlled.

MRN: MRN-2024-007 • 11/14/2024 • Notified: Dr. Priya Patel

Elevated phosphorus and PTH levels indicating secondary hyperparathyroidism. Consider adjusting phosphate binders and vitamin D therapy.